Solutions
Insulin
VanishPoint® Insulin Syringes
Immunization
VanishPoint® Syringes
EasyPoint® Needles
Blood Collection
EasyPoint® Blood Collection Tube with Needle
VanishPoint® Blood Collection Set
Allergy
VanishPoint® Syringes
General Purpose
VanishPoint® Syringes
EasyPoint® Needles
Infusion
VanishPoint® IV Catheters
Products
About
Careers
Investor Relations
Media
Blog
Press Releases
StikTalk
Resources
Contact
Questioning $1 Million Fee in a Needle Deal
rodneyhoganii
July 19, 2002
July 19, 2002
July 19, 2002
Press Releases
Questioning $1 Million Fee in a Needle Deal
Questioning $1 Million Fee in a Needle Deal
New York Times released an article today related to healthcare purchasing.
The article may be accessed by using the link below:
http://216.234.225.2/external.asp?b=577&id=69&from=pl
Previous Post
Next Post
YOU MAY ALSO LIKE
Related Posts
September 30, 2024
October 14, 2024
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
September 30, 2024
October 14, 2024
Retractable Technologies, Inc. Files Complaint in United States Court of International Trade
September 20, 2024
October 14, 2024
Tariffs Finalized on Chinese Imports